https://www.avient.com/news/archives?page=61
Avient Announces Second Quarter 2025 Results...
Avient Announces Quarterly Dividend...
Avient To Hold Second Quarter 2025 Conference Call...
https://www.avient.com/news/archives?page=79
Avient Announces Second Quarter 2025 Results...
Avient Announces Quarterly Dividend...
Avient To Hold Second Quarter 2025 Conference Call...
https://www.avient.com/news/archives?page=81
Avient Announces Second Quarter 2025 Results...
Avient Announces Quarterly Dividend...
Avient To Hold Second Quarter 2025 Conference Call...
https://www.avient.com/news/archives?page=67
Avient Announces Second Quarter 2025 Results...
Avient Announces Quarterly Dividend...
Avient To Hold Second Quarter 2025 Conference Call...
https://www.avient.com/news/archives?page=68
Avient Announces Second Quarter 2025 Results...
Avient Announces Quarterly Dividend...
Avient To Hold Second Quarter 2025 Conference Call...
https://www.avient.com/news/archives?page=41
Avient Announces Second Quarter 2025 Results...
Avient Announces Quarterly Dividend...
Avient To Hold Second Quarter 2025 Conference Call...
https://www.avient.com/news/archives?page=76
Avient Announces Second Quarter 2025 Results...
Avient Announces Quarterly Dividend...
Avient To Hold Second Quarter 2025 Conference Call...
https://www.avient.com/sites/default/files/2024-05/AVNT Q1 2024 Investor Presentation_website w Non-GAAP.pdf
Avient’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of Avient and each business segment and to allocate resources.
Each of such adjustments has not yet occurred, are out of Avient’s control and/or cannot be reasonably predicted.
FX -1.5% FX -0.5% Total Avient -2.0% Q 1 2024 R ES U LT S Q1 2024 PERFORMANCE VS.
https://www.avient.com/company/sustainability/sustainability-report/products/markets/healthcare-case-study
At Avient, we understand the need for medicine is an exact science, so our teams work closely with our customers to meet their demanding performance and regulatory requirements.
As the focus on sustainability continues to grow in the healthcare industry, Avient has continued to evolve our portfolio to meet our customers’ needs.
Avient’s newest Trilliant™ HC formulation not only provided improved chemical resistance over traditional nylon, it was developed a lower carbon footprint material.
https://www.avient.com/sites/default/files/2022-08/ColorMatrix Excelite Product Bulletin.pdf
EXCELITE CAN ENABLE ENHANCED PRODUCTION QUALITY Avient’s ColorMatrix metering equipment is highly accurate and delivers Excelite additives directly into the extruder/molder feed throat.
Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.
AVIENT MAKES NO WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, either with respect to the information or products reflected by the information.